“Demonstration of the Automated Dicentric Chromosome Identifier and Dose Estimator System (ADCI™) in a Cloud-based Online Environment”
at the International Atomic Energy Agency Coordinated Research Project (CRP) E35010: Applications of Biological Dosimetry Methods in Radiation Oncology, Nuclear Medicine, Diagnostic and Interventional Radiology (MEDBIODOSE)
Revised version of our review article on mRNA splicing in F1000Research has been highlighted in the Faculty of 1000 blog:
http://blog.f1000research.com/2015/03/17/interpreting-genomic-variants-in-rare-and-common-diseases/
The blog entry includes links to our YouTube video:
Short version (3:42)
Long version (9:41)
US Patent 8,209,129 has issued on single copy DNA probes which include divergent repetitive sequences, thus significantly extending the portions of the genome that can be used for such probes beyond traditional single copy sequences.
The technology also increases the density of genomic DNA probes for higher resolution genetic analysis beyond what is used in FISH, genomic microarrays for array comparative genomic hybridization, and solution capture hybrdization arrays for sequence enrichment in deep sequencing. It is licensed to Cytognomix.
Cytognomix’s new software product, the Shannon pipeline for human splicing mutation analysis of NGS sequencing data was presented at the BioIT World Conference and Expo (Apr 24-26, 2012), Boston.
Dr. Rogan describes our poster:
Large scale interpretation and stratification of non-coding sequence variants in the human genome. Ben Shirley1,Eliseos Mucaki2, & Peter Rogan1,2,3. Depts of Computer Science1 and Biochemistry2, and Cytognomix Inc3, London ON, Canada.
Cytognomix receives US Patent 7,734,424 entitled “AB INITIO GENERATION OF SINGLE COPY GENOMIC PROBES.”
Ontario Centre of Excellence for Commercialization of Research assists Cytognomix in building capacity through its Embedded Executive Program.
/
Canadian Institute for Photonic Innovations awards grant to the University of Western Ontario and Cytognomix through their Technology Exploitation and Networking Program.
MaRS Ventures Inc. (Toronto) accepts Cytognomix as a client of the Business Mentorship Entrepreneurship Program.
Cytognomix becomes a client of the NRC-IRAP program and receives an initial investment to create jobs in Ontario.